国药控股（股票代码：01099）于2026年7月6日发布2026年6月股份变动月报表。公告显示，截至2026年6月30日，公司股本结构保持稳定，未发生新增发行、购回或注销等变动。
根据公告，注册股本由H股与内资股构成，其中H股每股面值为人民币1元，上月底与本月底均为1,341,810,740股；内资股每股面值同为人民币1元，上月底与本月底同样维持在1,778,845,451股，合计注册股本总额为人民币3,120,656,191元。报告期内，未见任何股份期权或其他股权激励计划变动，也无库藏股、回购或注销情况。
公告同时确认，公司已符合香港联交所公开持股量要求。截至当前，国药控股股本维持不变。该公告由公司秘书吴壹建签署。公司强调将持续遵守香港联交所《上市规则》及相关法律法规要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.